Cartalax Pen – 20mg

Cartalax is a research peptide supplied in a convenient pre-filled pen designed for research into cartilage, connective tissue, joint biology and musculoskeletal pathways.

With 20mg of Cartalax and a precision click-based delivery system, the pen provides multiple dose options for controlled research protocols.

Product Specifications

• Product: Cartalax Pen
• Total peptide: 20mg
• Delivery format: Pre-filled peptide pen
• Dose selection: Precision click system
• Research applications: Cartilage, connective tissue, joint and musculoskeletal research

Cartalax Research

Cartalax has attracted research interest in relation to cartilage and connective-tissue biology, including pathways involved in tissue structure, cellular activity and musculoskeletal function.

Research areas may include:

• Cartilage-related pathways
• Connective-tissue research
• Joint biology
• Tissue-repair pathways
• Musculoskeletal research
• Mobility and structural-function research

Cartalax is therefore particularly relevant to research exploring how peptide compounds may interact with the biological processes associated with cartilage and connective tissue.

Research Dosing Reference

The following dosing information is based on the manufacturer-supplied research protocol and is provided for research reference only.

Low-dose research reference

• 0.5mg
• 6 clicks
• Approximately 40 doses per 20mg pen

Moderate-dose research reference

• 1mg
• 12 clicks
• Approximately 20 doses per pen

Higher-dose research reference

• 2mg
• 24 clicks
• Approximately 10 doses per pen

These figures are research references and should not be interpreted as recommended human dosing.

Precision Click-Based Delivery

The Cartalax Pen uses a multi-dose click system designed to provide measured dosing from a pre-filled format.

The click-based design allows researchers to select different research quantities from the same pen while avoiding manual peptide reconstitution.

Handling & Storage

Follow the storage instructions supplied with the product and protect the pen from excessive heat, light and environmental exposure.

Keep the pen capped when not in use and keep all research peptides out of reach of children.

Do not use research material if the solution appears cloudy, discoloured or contains visible particles.

Use appropriate laboratory handling and disposal procedures for research materials and associated sharps.

Important Notice

For research use only. Not intended for human consumption.

Cartalax is an experimental research peptide and is not an approved medicine for treating joint conditions, cartilage damage, pain, injuries or other medical conditions.

The information provided is for research and educational purposes only and does not constitute medical advice or a recommendation for human use.

This product is not intended to diagnose, treat, cure or prevent any disease. Statements regarding research applications have not been evaluated or approved by SAHPRA, the FDA or other regulatory authorities.

Always handle peptide products in accordance with appropriate laboratory safety and research protocols.